| [1] |
Nussbaum DP, Rushing CN, Lane WO, et al. Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database[J]. Lancet Oncol, 2016, 17(7):966-975.
doi: S1470-2045(16)30050-X
pmid: 27210906
|
| [2] |
Haas RLM, Bonvalot S, Miceli R, et al. Radiotherapy for retroperitoneal liposarcoma: a report from the Transatlantic Retroperitoneal Sarcoma Working Group[J]. Cancer, 2019, 125(8):1290-1300.
doi: 10.1002/cncr.31927
pmid: 30602058
|
| [3] |
Bonvalot S, Gronchi A, Le Péchoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2020, 21(10):1366-1377.
doi: S1470-2045(20)30446-0
pmid: 32941794
|
| [4] |
Callegaro D, Raut CP, Ajayi T, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) versus off-trial (STREXIT) results[J]. Ann Surg, 2022.[2022-10-08]. https://europepmc.org/article/MED/35833413.
|
| [5] |
Joung RHS, Wayne JD. Contemporary multimodal management of primary retroperitoneal sarcomas[J]. Adv Oncol, 2022, 2(1):63-69.
|
| [6] |
Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution[J]. Ann Surg, 1998, 228(3):355-365.
doi: 10.1097/00000658-199809000-00008
pmid: 9742918
|
| [7] |
Gronchi A, Miah AB, Dei Tos AP, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2021, 32(11):1348-1365.
doi: 10.1016/j.annonc.2021.07.006
pmid: 34303806
|
| [8] |
Allignet B, Sunyach MP, Geets X, et al. Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review[J]. Acta Oncol, 2022, 61(6):720-729.
doi: 10.1080/0284186X.2022.2066983
URL
|
| [9] |
Salerno KE, Baldini EH. Role of radiation therapy in retroperitoneal sarcoma[J]. J Natl Compr Canc Netw, 2022, 20(7):845-849.
doi: 10.6004/jnccn.2022.7035
URL
|
| [10] |
Dinges S, Budach V, Budach W, et al. Local recurrences of soft tissue sarcomas in adults: a retrospective analysis of prognostic factors in 102 cases after surgery and radiation therapy[J]. Eur J Cancer, 1994, 30A(11):1636-1642.
pmid: 7833136
|
| [11] |
Kepka L, DeLaney TF, Suit HD, et al. Results of radiation therapy for unresected soft-tissue sarcomas[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3):852-859.
doi: 10.1016/j.ijrobp.2005.03.004
URL
|
| [12] |
DeLaney TF, Haas RL. Innovative radiotherapy of sarcoma: proton beam radiation[J]. Eur J Cancer, 2016, 62:112-123.
doi: 10.1016/j.ejca.2016.04.015
pmid: 27258968
|
| [13] |
von Mehren M, Kane JM, Agulnik M, et al. Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(7):815-833.
doi: 10.6004/jnccn.2022.0035
URL
|
| [14] |
Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional(3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas[J]. Int J Radiat Oncol Biol Phys, 2012, 83(5):1549-1557.
doi: 10.1016/j.ijrobp.2011.10.014
URL
|
| [15] |
Chung C, Trofimov A, Adams J, et al. Comparison of 3D conformal proton therapy, intensity-modulated proton therapy, and intensity-modulated photon therapy for retroperitoneal sarcoma[J]. Sarcoma, 2022, 2022:5540615.
|
| [16] |
Schneider RA, Vitolo V, Albertini F, et al. Small bowel toxicity after high dose spot scanning-based proton beam therapy for paraspinal/retroperitoneal neoplasms[J]. Strahlenther Onkol, 2013, 189(12):1020-1025.
doi: 10.1007/s00066-013-0432-0
pmid: 24052010
|
| [17] |
Yoon SS, Chen YL, Kirsch DG, et al. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas[J]. Ann Surg Oncol, 2010, 17(6):1515-1529.
doi: 10.1245/s10434-010-0935-1
pmid: 20151216
|
| [18] |
DeLaney TF, Chen YL, Baldini EH, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas[J]. Adv Radiat Oncol, 2017, 2(1):85-93.
doi: 10.1016/j.adro.2016.12.003
pmid: 28740917
|
| [19] |
Minohara S, Fukuda S, Kanematsu N, et al. Recent innovations in carbon-ion radiotherapy[J]. J Radiat Res, 2010, 51(4):385-392.
pmid: 20679740
|
| [20] |
Kamada T, Tsujii H, Blakely EA, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience[J]. Lancet Oncol, 2015, 16(2):e93-e100.
doi: 10.1016/S1470-2045(14)70412-7
URL
|
| [21] |
Durante M, Yamada S, Ando K, et al. X-rays vs. carbo-nion tumor therapy: cytogenetic damage in lymphocytes[J]. Int J Radiat Oncol Biol Phys, 2000, 47(3):793-798.
doi: 10.1016/S0360-3016(00)00455-7
URL
|
| [22] |
Spina CS, Tsuruoka C, Mao W, et al. Differential immune modulation with carbon-ion versus photon therapy[J]. Int J Radiat Oncol Biol Phys, 2021, 109(3):813-818.
doi: 10.1016/j.ijrobp.2020.09.053
URL
|
| [23] |
Ming X, Wang W, Shahnazi K, et al. Dosimetric compa-rison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy[J]. Int J Radiat Biol, 2022, 98(2):183-190.
doi: 10.1080/09553002.2022.2009144
URL
|
| [24] |
Seidensaal K, Kieser M, Hommertgen A, et al. Neoadjuvant irradiation of retroperitoneal soft tissue sarcoma with ions (Retro-Ion): study protocol for a randomized phase Ⅱpilot trial[J]. Trials, 2021, 22(1):134.
doi: 10.1186/s13063-021-05069-z
pmid: 33579340
|
| [25] |
Serizawa I, Kagei K, Kamada T, et al. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas[J]. Int J Radiat Oncol Biol Phys, 2009, 75(4):1105-1110.
doi: 10.1016/j.ijrobp.2008.12.019
URL
|
| [26] |
Imai R, Kamada T, Araki N, et al. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma[J]. Cancer Med, 2018, 7(9):4308-4314.
doi: 10.1002/cam4.1679
URL
|
)
